Harvard Apparatus Regenerative Technology, Inc. (HRGN) — 8-K Filings

8-K Filings (9)

• Harvard Apparatus Regenerative Technology Files 8-K — Jul 14, 2025 Risk: medium
  On July 11, 2025, Harvard Apparatus Regenerative Technology, Inc. entered into a material definitive agreement. The company also reported on unregistered sales
• Harvard Apparatus Regenerative Technology Files 8-K on Shareholder Vote — Jun 24, 2025 Risk: low
  Harvard Apparatus Regenerative Technology, Inc. filed an 8-K on June 24, 2025, reporting on matters submitted to a vote of security holders as of June 20, 2025.
• HRGN Appoints New Auditor, BDO USA, LLP — Apr 14, 2025 Risk: low
  Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an 8-K on April 14, 2025, reporting a change in its certifying accountant. The company has appointe
• Harvard Apparatus Regenerative Technology Enters Material Agreement — Nov 6, 2024 Risk: medium
  On October 31, 2024, Harvard Apparatus Regenerative Technology, Inc. entered into a Material Definitive Agreement. The company, formerly known as Biostage, Inc.
• Harvard Apparatus Regenerative Tech Appoints New CMO, Director — Aug 27, 2024 Risk: medium
  Harvard Apparatus Regenerative Technology, Inc. announced on August 26, 2024, the appointment of Dr. David E. Pearlman as Chief Medical Officer and the election
• Harvard Apparatus Regenerative Technology Files 8-K — Aug 21, 2024 Risk: medium
  On August 19, 2024, Harvard Apparatus Regenerative Technology, Inc. entered into a material definitive agreement. The company also reported on unregistered sale
• HART Reports Shareholder Meeting Details — Jun 24, 2024 Risk: low
  Harvard Apparatus Regenerative Technology, Inc. (HART) filed an 8-K on June 24, 2024, reporting a shareholder meeting held on June 20, 2024. The primary purpose
• Harvard Apparatus Regenerative Technology Files 8-K — Apr 17, 2024 Risk: medium
  On April 15, 2024, Harvard Apparatus Regenerative Technology, Inc. entered into a material definitive agreement related to the sale of unregistered equity secur
• Harvard Apparatus RT Files 8-K on Material Agreement, Financial Obligation — Feb 6, 2024
  Harvard Apparatus Regenerative Technology, Inc. (formerly Biostage, Inc.) filed an 8-K on February 6, 2024, reporting an event that occurred on February 1, 2024

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX